Research Article
Increased Circulatory Interleukin-17A Levels in Patients with Progressive and Leukotrichial Vitiligo
Table 2
The association of serum IL-17A levels with clinical characteristics of vitiligo patients.
| Clinical characteristics | N | Serum IL-17 level (pg/mL) | value |
| Gender | Females | 34 | 3.12 (2.16–15.03) | 0.81 | Males | 18 | 2.78 (2.11–10.08) |
| Ages | ≤30 years | 21 | 10.68 (3.09–32.91) | 0.003 | >30 years | 31 | 2.78 (1.96–5.34) |
| Vitiligo activity | Stable | 17 | 2.26 (1.94–6.32) | 0.013 | Progressive | 35 | 4.35 (2.78–32.26) |
| Family history of vitiligo | Yes | 11 | 2.26 (1.96–49.10) | 0.69 | No | 41 | 3.09 (2.47–11.86) |
| Leukotrichia | Yes | 14 | 8.27 (2.78–122.62) | 0.04 | No | 38 | 2.99 (2.02–10.38) |
| Affected body surface area | <3% | 32 | 3.08 (2.24–12.02) | 0.82 | 3–10% | 13 | 4.35 (2.42–11.86) | >10% | 7 | 2.78 (1.78–16. |
|
|
values were obtained by the Mann–Whitney U test. Data were shown as median (25th–75th). |